Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: J Am Geriatr Soc. 2018 Nov 13;67(2):239–245. doi: 10.1111/jgs.15628

Table 1.

Summary statistics of study samplea

Characteristic Participants with
Any Self-Reported VIb
(n=3,933)
Participants with
No Self-Reported VI
(n=32,296)
P-valuec
Total, % (95% CI) 8.6 (8.0–9.2) 91.4 (90.8–92.0)
Age, years, % (95% CI) <0.001
 65–69 14.2 (12.3–16.4) 22.5 (21.7–23.2)
 70–74 17.5 (15.7–19.6) 29.3 (29.3–30.2)
 75–79 17.3 (15.3–19.4) 20.7 (20.0–21.5)
 80–84 17.4 (15.6–19.3) 14.6 (14.0–15.2)
 85–89 17.9 (16.2–19.7) 8.8 (8.2–9.3)
 90+ 15.7 (14.2–17.4) 4.1 (3.7–4.5)
Sex, % (95% CI) <0.001
 Male 34.4 (32.0–37.0) 44.7 (43.5–45.9)
 Female 65.6 (63.0–68.0) 55.3 (54.1–56.5)
Race/Ethnicity, % (95% CI) <0.001
 White 68.2 (64.3–72.0) 80.8 (79.1–82.4)
 Black 11.45 (9.8–13.3) 7.9 (7.1–8.7)
 Hispanic 13.7 (11.0–16.9) 6.1 (5.1–7.2)
 Other 6.6 (4.5–9.6) 5.2 (4.4–6.2)
Education, % (95% CI) <0.001
 <High school degree 36.5 (33.3–39.8) 17.8 (16.4–19.2)
 High school degree 28.2 (25.6–31.0) 26.7 (25.3–28.1)
 >High school degree 35.2 (32.0–38.6) 55.5 (53.4–57.7)
Medicaid Beneficiary <0.001
 Yes 28.1 (25.1–31.3) 11.2 (10.3–12.2)
 No 71.9 (68.6–74.9) 88.8 (87.7–89.7)
Body Mass Index, mean (95% CI) 27.4 (27.0–27.8) 27.8 (27.6–27.9) 0.04
Comorbidities, mean (95% CI) 2.9 (2.9–3.0) 2.3 (2.3–2.3) <0.001
Proxy Respondent, % (95% CI) <0.001
 No proxy 78.6 (76.1–81.0) 96.5 (96.1–96.9)
 Proxy 21.3 (19.0–23.9) 3.5 (3.1–3.9)

CI: confidence interval, VI: vision impairment

a

Data are presented as weighted proportions of US population of Medicare beneficiaries age ≥65, accounting for the study design of the National Health and Aging Trends Study

b

Includes participants who self-reported near and/or distance vision impairment

c

P values are unadjusted and calculated using design-adjusted Pearson chi-squared test for categorical variables and t-test for continuous/ordinal variables.